These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 64626
41. Herpes simplex virus (HSV) antigens on HSV-transformed rat cells can be demonstrated by rosette formation with Staphylococcus aureus protein-A-coated sheep red blood cells. Nachtigal M, Galatiuc C, Macnab JC. Intervirology; 1983; 20(1):42-7. PubMed ID: 6307919 [Abstract] [Full Text] [Related]
42. Transformation of cultured mammalian cells by viable herpes simplex virus subtypes 1 and 2. Garfinkle B, McAuslan BR. Proc Natl Acad Sci U S A; 1974 Jan; 71(1):220-4. PubMed ID: 4359329 [Abstract] [Full Text] [Related]
47. Immunoelectrophoretic identification and purification of herpes simplex virus antigens released from infected cells in tissue culture. Norrild B, Vestergaard BF. Intervirology; 1979 Jan; 11(2):104-10. PubMed ID: 85610 [Abstract] [Full Text] [Related]
48. Demonstration of HSV-I antigen in patients with oral cancer by immunofluorescence and immunoperoxidase techniques. Kumari TV, Vasudevan DM, Ankathil R, Ramani P, Vijayakumar T. J Exp Pathol; 1987 Jan; 3(1):75-86. PubMed ID: 2824733 [Abstract] [Full Text] [Related]
49. Immunoblotting and ELISA analysis of HSV-1 and HSV-2-specified polypeptides by using an immunoblocking method. Lehtinen M. Ann Clin Res; 1985 Jan; 17(2):66-70. PubMed ID: 2412480 [Abstract] [Full Text] [Related]
50. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities. Yasukawa M, Zarling JM. J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243 [Abstract] [Full Text] [Related]
52. Reactivity of human sera with overlapping synthetic peptides of herpes simplex virus type 1 glycoprotein D. Geerligs HJ, Feijlbrief M, Bolk M, Bos CA, Drijfhout JW, Welling GW, Welling-Wester S. Arch Virol; 1990 Nov; 114(3-4):251-8. PubMed ID: 2173527 [Abstract] [Full Text] [Related]
53. Fucolipid patterns of cell lines transformed by highly and weakly tumorigenic simian virus 40 and herpes simplex virus. Steiner S, Steiner MR. Intervirology; 1990 Nov; 6(1):32-41. PubMed ID: 178626 [Abstract] [Full Text] [Related]
54. Spleen cell-mediated cytotoxicity of hamster cells transformed by Herpes simplex virus: evidence for virus-specific membrane antigen. Lausch RN, Jones C, Christie D, Hay KA, Rapp F. J Immunol; 1975 Jan; 114(1 Pt 2):459-65. PubMed ID: 163859 [Abstract] [Full Text] [Related]
55. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients. Notter MF, Docherty JJ. Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320 [Abstract] [Full Text] [Related]
56. Vaccinia virus, herpes simplex virus, and carcinogens induce DNA amplification in a human cell line and support replication of a helpervirus dependent parvovirus. Schlehofer JR, Ehrbar M, zur Hausen H. Virology; 1986 Jul 15; 152(1):110-7. PubMed ID: 3012864 [Abstract] [Full Text] [Related]
57. Crossed immunoelectrophoresis of a herpes simplex virus type 1-specific antigen: immunological and biochemical characterization. Vestergaard BF, Norrild B. J Infect Dis; 1978 Nov 15; 138(5):639-43. PubMed ID: 81867 [Abstract] [Full Text] [Related]
59. Specific induction of cellular gene transcription in herpes simplex virus type 2-transformed cells. Filion M, Skup D, Suh M. J Gen Virol; 1988 Aug 15; 69 ( Pt 8)():2011-9. PubMed ID: 2841413 [Abstract] [Full Text] [Related]